Interferon alfacon-1: new preparation. Basically a me-too interferon alfa.
Interferon alfacon-1 differs from other interferon alfa preparations by only a few amino acids. In patients with chronic active hepatitis C, two comparative trials show that interferon alfacon-1 has the same activity and adverse effects as other interferons alfa. Interferon alfacon-1 is less easy to administer.
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005602:France; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins